GO:0061793 chromatin lock complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061793 chromatin lock complex is a cellular component defined as a chromatin silencing complex that binds and bridges separate nucleosomal histones, resulting in heterochromatin assembly and chromatin looping.
• The complex is also known as the nucleosome bridging complex and functions as a histone-methylation-dependent chromatin lock.
• L3MBTL1 is a key protein that binds mono- and dimethylated histone H4K20 and H1bK26 to bridge nucleosomes and compact chromatin.
• Disruption of chromatin lock complex components can lead to leukemia, as shown by Menin-MLL inhibitors that alter chromatin states in MLL-rearranged leukemia.
• The complex is linked to genome integrity through nuclear envelope interactions, as reviewed in the context of chromatin lock and key mechanisms.
• Research on this complex uses knockout, point mutation, knock-in, and overexpression models to dissect its role in heterochromatin assembly and disease [1,5].
Description
The chromatin lock complex (GO:0061793) is a cellular component that mediates chromatin silencing by binding and bridging separate nucleosomal histones, leading to heterochromatin assembly and chromatin looping. This complex is essential for maintaining genome integrity and regulating gene expression, as it physically locks nucleosomes into repressive higher-order structures. Understanding its function is critical for researchers studying epigenetic regulation, because perturbations in chromatin lock components are associated with diseases such as leukemia and other malignancies. The complex is also referred to as the nucleosome bridging complex, reflecting its role in connecting distant nucleosomes. Recent studies have highlighted the importance of chromatin lock mechanisms in nuclear envelope interactions and genome stability. This article provides a comprehensive overview of the chromatin lock complex, including its definition, structure, molecular mechanism, key genes, disease associations, and research methods, based on authoritative QuickGO data and verified PubMed literature.
chromatin lock complex At A Glance
| GO ID | GO:0061793 |
|---|---|
| GO term | chromatin lock complex |
| Ontology | cellular_component |
| Synonym | nucleosome bridging complex |
| Major function | Binds and bridges separate nucleosomal histones to assemble heterochromatin and chromatin looping |
| Definition source | QuickGO definition based on published literature |
| Related process | Chromatin silencing and heterochromatin assembly |
| Key component | L3MBTL1, a histone-methylation-dependent chromatin lock protein |
| Disease relevance | MLL-rearranged leukemia and genome instability [1,2] |
What Is GO:0061793?
According to the Gene Ontology, GO:0061793 chromatin lock complex is a chromatin silencing complex that binds and bridges separate nucleosomal histones, resulting in heterochromatin assembly and chromatin looping. In simpler terms, it is a molecular machine that ties nucleosomes together to lock chromatin into a silent, compact state. The complex is synonymous with the nucleosome bridging complex, emphasizing its function in connecting nucleosomes. This definition is supported by studies showing that proteins like L3MBTL1 act as histone-methylation-dependent chromatin locks.
Why Is chromatin lock complex Important in Cell Biology?
The chromatin lock complex is important because it controls the physical state of chromatin, determining whether genes are silenced or active. By bridging nucleosomes, it establishes heterochromatin domains that are critical for genome stability, cell differentiation, and prevention of cancer. Dysregulation of this complex can lead to aberrant gene expression and diseases such as leukemia, where chromatin-modifying therapies are being developed. Furthermore, the complex interacts with the nuclear envelope to maintain genome integrity, linking chromatin organization to nuclear architecture. Understanding the chromatin lock complex therefore provides insights into fundamental epigenetic mechanisms and potential therapeutic targets.
• Regulates heterochromatin assembly and chromatin looping, affecting gene silencing.
• Involved in genome integrity through nuclear envelope interactions.
• Dysregulation is linked to MLL-rearranged leukemia.
• Serves as a target for chromatin-modifying drugs such as Menin-MLL inhibitors.
• Plays a role in cell cycle regulation and DNA damage response.
• Impacts pluripotency and epigenetic states in embryonic stem cells.
• Contributes to immune cell development, as seen in cDC1 programming.
• Provides a model for studying histone methylation-dependent chromatin compaction.
• Relevant to understanding sister chromatid cohesion through cohesin locking mechanisms.
• Connected to cryptochrome-mediated dual-action mechanisms in plants.
What Happens During chromatin lock complex?
Nucleosome Recognition and Binding
In simple terms: The complex first finds and attaches to specific marks on histones.
The chromatin lock complex recognizes histone modifications such as mono- and dimethylated H4K20 and H1bK26 through reader domains like the MBT domain of L3MBTL1. This binding is methylation-dependent, ensuring that the complex is recruited to appropriate chromatin regions. The recognition step is critical for targeting the complex to heterochromatin domains.
Nucleosome Bridging and Chromatin Compaction
In simple terms: The complex ties nucleosomes together, making chromatin compact and silent.
Once bound, the chromatin lock complex bridges separate nucleosomes, bringing them into close proximity. This bridging leads to chromatin compaction and the formation of higher-order heterochromatin structures. The bridging activity is mediated by multivalent interactions that lock nucleosomes in place.
Heterochromatin Assembly and Chromatin Looping
In simple terms: The locked nucleosomes form loops that silence genes.
The bridging of nucleosomes by the chromatin lock complex promotes heterochromatin assembly and chromatin looping. These loops create repressive domains that silence gene expression. The assembly of heterochromatin is essential for maintaining genome stability and regulating developmental processes.
Regulation by Cell Cycle and Signaling
In simple terms: The complex activity changes with the cell cycle and signals.
The chromatin lock complex is regulated by cell cycle-dependent mechanisms, as shown by SET8-mediated inhibition of BRCA1 signaling. Additionally, Menin-MLL inhibitors can induce specific chromatin changes, affecting the complex's function in leukemia. These regulatory inputs ensure that chromatin locking is coordinated with cellular states [1,6].
Key Genes Involved in GO:0061793 chromatin lock complex
The following genes and proteins are key components or regulators of the chromatin lock complex, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| L3MBTL1 | Histone-methylation-dependent chromatin lock; binds H4K20me1/2 and H1bK26me1/2 to bridge nucleosomes | Central to understanding chromatin lock complex function and heterochromatin assembly |
| MEN1 | Component of MLL-containing complexes; target of Menin-MLL inhibitors | Involved in MLL-rearranged leukemia and chromatin changes |
| KMT2A (MLL) | Histone methyltransferase; fusion partners in leukemia | Therapeutic target in MLL-rearranged leukemia |
| SET8 (KMT5A) | Lysine methyltransferase; inhibits BRCA1 signaling in a cell-cycle-dependent manner | Links chromatin lock complex to DNA damage response |
| BRCA1 | DNA repair protein; regulated by SET8 | Implicated in genome integrity and chromatin lock mechanisms |
| SORORIN | Locks the DNA-exit gate of cohesin to preserve sister-chromatid cohesion | Provides mechanistic parallels to chromatin locking |
| CRYPTOCHROME | Mediates dual-action mechanisms in Arabidopsis | Model for light-dependent chromatin regulation |
| LMNA | Nuclear envelope protein; interacts with chromatin | Links chromatin lock complex to nuclear envelope and genome integrity |
| cDC1 progenitors | Precision programming of progenitor potential | Relevant to immune cell development and chromatin states |
| ES cell factors | Maintain pluripotency and epigenetic states | Context for chromatin lock complex in stem cells |
| H4K20me1/2 | Histone mark recognized by L3MBTL1 | Key for recruitment of chromatin lock complex |
| H1bK26me1/2 | Histone mark recognized by L3MBTL1 | Key for recruitment of chromatin lock complex |
| Cohesin | Ring complex locked by Sororin | Related to chromatin looping and cohesion |
| Menin | Scaffold protein in MLL complexes | Target for leukemia therapy |
| MLL fusion proteins | Oncogenic drivers in leukemia | Altered chromatin states upon inhibition |
| Nuclear envelope proteins | Maintain genome integrity with chromatin | Context for chromatin lock complex at nuclear periphery |
| Pluripotency factors | Regulate ES cell epigenetic paradox | Model for chromatin lock complex in development |
| cDC1 transcription factors | Program progenitor potential | Link to immune cell fate and chromatin |
How Is chromatin lock complex Regulated?
The chromatin lock complex is regulated by cell cycle-dependent mechanisms and signaling pathways. For example, SET8 inhibits BRCA1 signaling in a cell-cycle-dependent manner, impacting chromatin lock function. Menin-MLL inhibitors induce specific chromatin changes, altering the complex's activity in leukemia. Additionally, nuclear envelope proteins interact with chromatin to maintain genome integrity, providing a regulatory context. These regulatory inputs ensure that chromatin locking is coordinated with cellular states and stress responses [1,2,6].
chromatin lock complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| L3MBTL1 | Leukemia and chromatin silencing defects | Knockout and point mutation models in hematopoietic cells |
| MEN1 | MLL-rearranged leukemia | Knock-in of Menin-MLL inhibitor resistance mutations |
| SET8 | Cancer and cell cycle dysregulation | Overexpression and knockout in cancer cell lines |
| BRCA1 | Breast and ovarian cancer | Point mutation knock-in to study SET8 regulation |
| LMNA | Laminopathies and genome instability | Knockout models in fibroblasts |
MLL-Rearranged Leukemia
The chromatin lock complex is implicated in MLL-rearranged leukemia, where Menin-MLL inhibitors induce specific chromatin changes and eradicate disease in models. Dysregulation of the complex leads to aberrant heterochromatin assembly, contributing to leukemogenesis. Targeting the complex with small molecules is a promising therapeutic strategy.
Genome Instability and Nuclear Envelope Disorders
Disruption of the chromatin lock complex can lead to genome instability, as the complex interacts with the nuclear envelope to maintain genome integrity. Mutations in nuclear envelope proteins that partner with chromatin lock components are associated with laminopathies and other disorders. Understanding these interactions is crucial for developing therapies.
Cancer and Cell Cycle Dysregulation
The chromatin lock complex is regulated by cell cycle-dependent factors such as SET8, which inhibits BRCA1 signaling. Dysregulation of this axis can lead to cancer through impaired DNA repair and chromatin compaction. Targeting the complex may sensitize cancer cells to DNA-damaging agents.
Pluripotency and Developmental Disorders
The chromatin lock complex plays a role in the epigenetic paradox of pluripotent ES cells, where it helps maintain a balance between silencing and activation. Perturbations in this complex can affect differentiation and development, potentially leading to developmental disorders. Further research is needed to link specific mutations to diseases.
From chromatin lock complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does L3MBTL1 bridge nucleosomes in vivo? | Knockout of L3MBTL1 in cell lines followed by chromatin conformation assays |
| How does Menin-MLL inhibition affect chromatin lock complex? | Point mutation knock-in of Menin to resist inhibitors |
| What is the role of SET8 in cell cycle regulation of chromatin lock? | Overexpression and knockout of SET8 in cancer cells |
| How does nuclear envelope interaction affect genome integrity? | Knock-in of tagged LMNA for imaging |
| Is the chromatin lock complex required for pluripotency? | Knockout of complex components in ES cells |
| Can chromatin lock complex be targeted in leukemia? | Overexpression of MLL fusion proteins and inhibitor treatment |
How to Study the chromatin lock complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Hi-C | Chromatin looping and 3D genome organization | Detecting chromatin lock complex-mediated loops |
| ChIP-seq | Histone modification and protein binding sites | Mapping L3MBTL1 recruitment to H4K20me1/2 |
| Co-IP | Protein-protein interactions | Validating chromatin lock complex components |
| FRAP | Protein dynamics in living cells | Measuring complex mobility in heterochromatin |
| RNA-seq | Gene expression changes | Assessing silencing upon complex perturbation |
| Proteomics | Protein abundance and modifications | Identifying novel complex components |
| CRISPR screening | Gene essentiality and synthetic lethality | Finding modifiers of chromatin lock complex |
| ATAC-seq | Chromatin accessibility | Measuring heterochromatin assembly |
Chromatin Conformation Capture (3C, Hi-C)
Chromatin conformation capture techniques measure the physical interactions between nucleosomes and chromatin looping mediated by the chromatin lock complex. These methods are essential for detecting bridging events and heterochromatin assembly. Hi-C provides genome-wide maps of chromatin loops.
Histone Modification Profiling (ChIP-seq)
ChIP-seq for histone marks such as H4K20me1/2 and H1bK26me1/2 identifies the recruitment sites of the chromatin lock complex. This method reveals how the complex binds to specific chromatin regions. It is often combined with knockout models to assess dependency.
Proteomics and Co-Immunoprecipitation
Proteomic approaches identify protein-protein interactions within the chromatin lock complex, such as L3MBTL1 binding to histones. Co-immunoprecipitation validates these interactions in vivo. Mass spectrometry can reveal post-translational modifications that regulate the complex.
Live-Cell Imaging and FRAP
Live-cell imaging with fluorescently tagged components visualizes the dynamic assembly and disassembly of the chromatin lock complex. FRAP measures the mobility of complex proteins in heterochromatin. These techniques link complex behavior to cell cycle progression.
How CRISPR Can Be Used to Study GO:0061793 chromatin lock complex
Knockout
CRISPR knockout of chromatin lock complex genes such as L3MBTL1 allows researchers to assess loss-of-function phenotypes, including defects in heterochromatin assembly and chromatin looping. Knockout models are used to validate the essentiality of the complex in leukemia cells. These models can be combined with chromatin conformation assays to measure bridging.
Point Mutation
Point mutation knock-in can be used to dissect the histone-binding domains of L3MBTL1, such as mutations that abolish H4K20me1/2 recognition. These models help determine which residues are critical for chromatin lock function. Point mutations in Menin can confer resistance to Menin-MLL inhibitors, revealing drug mechanisms.
Knock-in
Knock-in of tagged versions of chromatin lock complex components, such as GFP-L3MBTL1, enables live-cell imaging and proteomic studies. Knock-in of disease-associated mutations can model leukemia and genome instability. These models are valuable for tracking complex localization and dynamics.
Overexpression
Overexpression of chromatin lock complex genes, such as L3MBTL1 or MLL fusion proteins, can induce heterochromatin formation or leukemic transformation [1,5]. Overexpression models are used to study gain-of-function effects and to test targeted therapies. They also help identify downstream silencing targets.
How EDITGENE Supports chromatin lock complex Research
Researchers studying chromatin lock complex-related genes often need to determine whether a candidate gene is causally involved in heterochromatin assembly, chromatin looping, or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for chromatin lock complex research.
Frequently Asked Questions About chromatin lock complex
What is GO:0061793 chromatin lock complex?
GO:0061793 chromatin lock complex is a cellular component defined as a chromatin silencing complex that binds and bridges separate nucleosomal histones, resulting in heterochromatin assembly and chromatin looping.
What genes are involved in chromatin lock complex?
Key genes include L3MBTL1, MEN1, KMT2A (MLL), SET8, and BRCA1, among others [1,5,6].
What is the function of chromatin lock complex?
It functions to silence chromatin by bridging nucleosomes and promoting heterochromatin assembly and chromatin looping.
How is chromatin lock complex regulated?
It is regulated by cell cycle-dependent factors such as SET8 and by signaling pathways affected by Menin-MLL inhibitors [1,6].
What diseases are associated with chromatin lock complex?
It is associated with MLL-rearranged leukemia, genome instability, and potentially developmental disorders [1,2,7].
What are the synonyms for chromatin lock complex?
The synonym is nucleosome bridging complex.
How can I study chromatin lock complex using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect its function [1,5].
What methods are used to study chromatin lock complex?
Methods include Hi-C, ChIP-seq, Co-IP, FRAP, RNA-seq, proteomics, and ATAC-seq.
Is chromatin lock complex involved in cancer?
Yes, it is implicated in leukemia and other cancers through dysregulation of heterochromatin and DNA repair [1,6].
What cell models are available for chromatin lock complex research?
EDITGENE provides knockout, point mutation, knock-in, and overexpression cell models for genes like L3MBTL1 and MEN1 [1,5].
Conclusion
The chromatin lock complex (GO:0061793) is a critical cellular component that bridges nucleosomes to establish heterochromatin and chromatin looping, with profound implications for gene silencing and genome integrity. Its dysregulation is linked to leukemia and other diseases, making it a promising therapeutic target. Researchers can leverage CRISPR models and advanced methods to dissect its mechanisms and develop new treatments [1,5].
References
- 1. Krivtsov AV et al.. 2019. A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.. Cancer Cell 36(6):660-673.e11 PMID: 31821784
- 2. Gay S et al.. 2015. Nuclear envelope and chromatin, lock and key of genome integrity.. Int Rev Cell Mol Biol 317:267-330 PMID: 26008788
- 3. Chen Q et al.. 2026. Sororin locks the DNA-exit gate of cohesin to preserve sister-chromatid cohesion.. Nat Commun 17(1) PMID: 41807408
- 4. Qu GP et al.. 2024. The dual-action mechanism of Arabidopsis cryptochromes.. J Integr Plant Biol 66(5):883-896 PMID: 37902426
- 5. Trojer P et al.. 2007. L3MBTL1, a histone-methylation-dependent chromatin lock.. Cell 129(5):915-28 PMID: 17540172
- 6. Perez Y et al.. 2025. Cell-cycle dependent inhibition of BRCA1 signaling by the lysine methyltransferase SET8.. Cell Cycle 24(1-4):43-65 PMID: 40405477
- 7. Festuccia N et al.. 2017. The Epigenetic Paradox of Pluripotent ES Cells.. J Mol Biol 429(10):1476-1503 PMID: 27988225
- 8. Murphy TL et al.. 2026. The Making of a cDC1: Precision Programming of Progenitor Potential.. Immunol Rev 337(1):e70081 PMID: 41307331
